49 related articles for article (PubMed ID: 2895613)
1. Alpha-adrenoceptor-blocking properties of some trypanocidal diamidines.
Steinmann U; Estler CJ; Dann O
Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):207-14. PubMed ID: 2895613
[TBL] [Abstract][Full Text] [Related]
2. Effects of nipradilol (K-351) on alpha-adrenoceptor mediated responses in various isolated tissues.
Ohira A; Wada Y; Fujii M; Nakamura M; Kasuya Y; Hamada Y; Shigenobu K
Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):61-71. PubMed ID: 2869737
[TBL] [Abstract][Full Text] [Related]
3. A new beta 2-adrenoceptor agonist with alpha 1-adrenoceptor blocking properties.
Olsson OA; Ahlquist B; Gustafsson B
Acta Pharmacol Toxicol (Copenh); 1981 Apr; 48(4):340-8. PubMed ID: 6121453
[TBL] [Abstract][Full Text] [Related]
4. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
Pittner H
Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
[TBL] [Abstract][Full Text] [Related]
5. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
Miyagishi A; Nakahara H; Hara Y
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the alpha-adrenoceptor antagonistic action of berberine in isolated organs.
Olmez E; Ilhan M
Arzneimittelforschung; 1992 Sep; 42(9):1095-7. PubMed ID: 1359895
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic characterization of SK&F 104078, a novel alpha-2 adrenoceptor antagonist which discriminates between pre- and postjunctional alpha-2 adrenoceptors.
Hieble JP; Sulpizio AC; Nichols AJ; Willette RN; Ruffolo RR
J Pharmacol Exp Ther; 1988 Nov; 247(2):645-52. PubMed ID: 2903236
[TBL] [Abstract][Full Text] [Related]
8. CH-38083, a selective, potent antagonist of alpha-2 adrenoceptors.
Vizi ES; Harsing LG; Gaal J; Kapocsi J; Bernath S; Somogyi GT
J Pharmacol Exp Ther; 1986 Aug; 238(2):701-6. PubMed ID: 2874217
[TBL] [Abstract][Full Text] [Related]
9. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
[TBL] [Abstract][Full Text] [Related]
10. Antinoradrenergic activity of thymoxamine and its metabolites in rats.
Roquebert J; Demichel P; Malek A
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):12-25. PubMed ID: 6111983
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic activity of aligeron and papaverine against different smooth muscle stimuli.
Miyares K; Delfin M; Nikolov R; Nikolova M
Methods Find Exp Clin Pharmacol; 1985 Sep; 7(9):473-6. PubMed ID: 4079597
[TBL] [Abstract][Full Text] [Related]
12. The alpha-adrenoceptor blocking properties of cryptolepine on the rat isolated vas deferens. Studies on cryptolepine.
Noamesi BK; Bamgbose SO
Planta Med; 1980 May; 39(1):51-6. PubMed ID: 6105685
[No Abstract] [Full Text] [Related]
13. [Action of dihydroergocristine at pre- and postsynaptic alpha-adrenoceptors in the rat isolated vas deferens].
Roquebert J; Demichel P; Gomond P; Malek A
J Pharmacol; 1983; 14(2):151-9. PubMed ID: 6134866
[TBL] [Abstract][Full Text] [Related]
14. Some pharmacological actions of nisoxetine, a bicyclic inhibitor of noradrenaline uptake.
Leedham JA; Foley AJ; Pennefather JN
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):39-55. PubMed ID: 2998294
[TBL] [Abstract][Full Text] [Related]
15. Alpha-adrenergic receptor blocking effect of Cleistanthus collinus (Roxb.) Benth. and Hook f. leaf extract on guinea pig isolated smooth muscle preparations.
Kumar MR; Ramaswamy S; Jayanthi M; Raveendran R
Indian J Exp Biol; 2011 May; 49(5):339-42. PubMed ID: 21615057
[TBL] [Abstract][Full Text] [Related]
16. Quantitative assessment of the pre- and postsynaptic alpha adrenoceptor antagonist potency of amitriptyline.
Leighton HJ
J Pharmacol Exp Ther; 1982 Feb; 220(2):299-304. PubMed ID: 6120225
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
Aono J; Nabata H; Ishizuka N; Sakai K
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
[TBL] [Abstract][Full Text] [Related]
19. [Comparative study of the pre and post-synaptic alpha blocking activity of thymoxamine and its metabolites in the rat vas deferens (author's transl)].
Roquebert J; Demichel P; Malek A; Canellas J
J Pharmacol; 1981; 12(1):15-25. PubMed ID: 6111626
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of a 2-piperazinotetralin (P-11)--combined alpha- and beta-adrenoceptor blocking drug with hypotensive action.
Mutafova-Yambolieva V; Staneva-Stoytcheva D
Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):551-7. PubMed ID: 2906393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
